{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T07:19:24Z","timestamp":1760080764650,"version":"3.44.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T00:00:00Z","timestamp":1669766400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002822","name":"Central South University","doi-asserted-by":"publisher","award":["2020CX015"],"award-info":[{"award-number":["2020CX015"]}],"id":[{"id":"10.13039\/501100002822","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019081","name":"Science and Technology Program of Hunan Province","doi-asserted-by":"publisher","award":["2020RC4009"],"award-info":[{"award-number":["2020RC4009"]}],"id":[{"id":"10.13039\/501100019081","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.lfs.2022.121238","type":"journal-article","created":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T02:54:12Z","timestamp":1669690452000},"page":"121238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Identification and validation of key immune-related genes with promising diagnostic and predictive value in systemic sclerosis"],"prefix":"10.1016","volume":"312","author":[{"given":"Yajie","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingxin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Limin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haowei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuo","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10103","key":"10.1016\/j.lfs.2022.121238_bb0005","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2022.121238_bb0010","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3389\/fimmu.2015.00272","article-title":"Pathogenesis of systemic sclerosis","volume":"6","author":"Pattanaik","year":"2015","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.lfs.2022.121238_bb0015","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/1346-8138.14153","article-title":"Systemic sclerosis","volume":"45","author":"Asano","year":"2018","journal-title":"J. Dermatol."},{"issue":"18","key":"10.1016\/j.lfs.2022.121238_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20184337","article-title":"Exosomes in systemic sclerosis: messengers between immune, vascular and fibrotic components?","volume":"20","author":"Colletti","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.lfs.2022.121238_bb0025","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/1346-8138.14538","article-title":"Serum interleukin-34 levels in patients with systemic sclerosis: clinical association with interstitial lung disease","volume":"45","author":"Kuzumi","year":"2018","journal-title":"J. Dermatol."},{"issue":"3","key":"10.1016\/j.lfs.2022.121238_bb0030","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/cei.13238","article-title":"The immunopathogenesis of fibrosis in systemic sclerosis","volume":"195","author":"Brown","year":"2019","journal-title":"Clin. Exp. Immunol."},{"issue":"21","key":"10.1016\/j.lfs.2022.121238_bb0035","doi-asserted-by":"crossref","first-page":"12319","DOI":"10.1073\/pnas.1635114100","article-title":"Systemic and cell type-specific gene expression patterns in scleroderma skin","volume":"100","author":"Whitfield","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.lfs.2022.121238_bb0040","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13075-018-1569-0","article-title":"Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression","volume":"20","author":"Bosello","year":"2018","journal-title":"Arthritis Res.Ther."},{"issue":"4","key":"10.1016\/j.lfs.2022.121238_bb0045","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.4049\/jimmunol.0901778","article-title":"Cell adhesion molecules regulate fibrotic process via Th1\/Th2\/Th17 cell balance in a bleomycin-induced scleroderma model","volume":"185","author":"Yoshizaki","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2022.121238_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2019.154799","article-title":"Interleukin-4 and interleukin-13 as possible therapeutic targets in systemic sclerosis","volume":"125","author":"Gasparini","year":"2020","journal-title":"Cytokine"},{"issue":"6","key":"10.1016\/j.lfs.2022.121238_bb0055","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/BOR.0000000000000657","article-title":"Macrophages and cadherins in fibrosis and systemic sclerosis","volume":"31","author":"To","year":"2019","journal-title":"Curr. Opin. Rheumatol."},{"issue":"1","key":"10.1016\/j.lfs.2022.121238_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004005","article-title":"Systems level analysis of systemic sclerosis shows a network of immune and profibrotic pathways connected with genetic polymorphisms","volume":"11","author":"Mahoney","year":"2015","journal-title":"PLoS Comput. Biol."},{"issue":"5","key":"10.1016\/j.lfs.2022.121238_bb0065","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41590-020-0654-0","article-title":"Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation","volume":"21","author":"Mendiola","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.lfs.2022.121238_bb0070","doi-asserted-by":"crossref","first-page":"D991","DOI":"10.1093\/nar\/gks1193","article-title":"NCBI GEO: archive for functional genomics data sets\u2013update","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1016\/j.lfs.2022.121238_bb0075","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.lfs.2022.121238_bb0080","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s12026-014-8516-1","article-title":"ImmPort: disseminating data to the public for the future of immunology","volume":"58","author":"Bhattacharya","year":"2014","journal-title":"Immunol. Res."},{"issue":"4","key":"10.1016\/j.lfs.2022.121238_bb0085","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","article-title":"Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer","volume":"39","author":"Bindea","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.lfs.2022.121238_bb0090","doi-asserted-by":"crossref","first-page":"D1049","DOI":"10.1093\/nar\/gku1179","article-title":"Gene Ontology Consortium: going forward","volume":"43","year":"2015","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/j.lfs.2022.121238_bb0095","doi-asserted-by":"crossref","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","article-title":"KEGG: new perspectives on genomes, pathways, diseases and drugs","volume":"45","author":"Kanehisa","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.lfs.2022.121238_bb0100","doi-asserted-by":"crossref","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","article-title":"The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets","volume":"49","author":"Szklarczyk","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.lfs.2022.121238_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.642891","article-title":"Elevated fibronectin levels in profibrotic CD14 monocytes and CD14 macrophages in systemic sclerosis","volume":"12","author":"Rudnik","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2022.121238_bb0110","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/14397595.2020.1726599","article-title":"Up-regulation of IGF-1, RANTES and VEGF in patients with anti-centromere antibody-positive early\/mild systemic sclerosis","volume":"31","author":"Tabata","year":"2021","journal-title":"Mod. Rheumatol."},{"issue":"4","key":"10.1016\/j.lfs.2022.121238_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygeno.2022.110391","article-title":"MicroRNA-27a-3p inhibits lung and skin fibrosis of systemic sclerosis by negatively regulating SPP1","volume":"114","author":"Cheng","year":"2022","journal-title":"Genomics"},{"issue":"6","key":"10.1016\/j.lfs.2022.121238_bb0120","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/jid.2012.32","article-title":"Osteopontin in systemic sclerosis and its role in dermal fibrosis","volume":"132","author":"Wu","year":"2012","journal-title":"J.Investig.Dermatol."},{"issue":"6","key":"10.1016\/j.lfs.2022.121238_bb0125","first-page":"1027","article-title":"[Increased serum soluble-endoglin level and its clinical significance in antiphospholipid syndrome]","volume":"50","author":"Li","year":"2018","journal-title":"Beijing Da Xue Xue Bao"},{"issue":"4","key":"10.1016\/j.lfs.2022.121238_bb0130","first-page":"373","article-title":"Dermal elastin and collagen in systemic sclerosis. Effect of D-penicillamine treatment","volume":"7","author":"Pasquali Ronchetti","year":"1989","journal-title":"Clin. Exp. Rheumatol."},{"issue":"3","key":"10.1016\/j.lfs.2022.121238_bb0135","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.autrev.2017.10.015","article-title":"Altered B lymphocyte homeostasis and functions in systemic sclerosis","volume":"17","author":"Forestier","year":"2018","journal-title":"Autoimmun. Rev."},{"issue":"9","key":"10.1016\/j.lfs.2022.121238_bb0140","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1002\/art.40171","article-title":"CCL2 in the circulation predicts long-term progression of interstitial lung disease in patients with early systemic sclerosis: data from two independent cohorts","volume":"69","author":"Wu","year":"2017","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"10.1016\/j.lfs.2022.121238_bb0145","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/rheumatology\/kem313","article-title":"CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis\u2013a longitudinal study","volume":"47","author":"Antonelli","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.lfs.2022.121238_bb0150","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cytogfr.2015.12.002","article-title":"New insights into CD4(+) T cell abnormalities in systemic sclerosis","volume":"28","author":"Liu","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"issue":"6","key":"10.1016\/j.lfs.2022.121238_bb0155","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1007\/s10067-018-4081-7","article-title":"Increased serum levels of adhesion molecules ICAM-1 and VCAM-1 in systemic sclerosis are not specific for pulmonary manifestations","volume":"37","author":"Thakkar","year":"2018","journal-title":"Clin. Rheumatol."},{"issue":"18","key":"10.1016\/j.lfs.2022.121238_bb0160","doi-asserted-by":"crossref","first-page":"4534","DOI":"10.1111\/bph.15898","article-title":"Targeted nanotherapy with everolimus reduces inflammation and fibrosis in scleroderma-related interstitial lung disease developed by PSGL-1 deficient mice","volume":"179","author":"Gonz\u00e1lez-S\u00e1nchez","year":"2022","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.lfs.2022.121238_bb0165","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s11596-008-0424-y","article-title":"Expression of MMP-9 and TIMP-1 in lesions of systemic sclerosis and its implications","volume":"28","author":"Meng","year":"2008","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."},{"key":"10.1016\/j.lfs.2022.121238_bb0170","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3389\/fimmu.2015.00496","article-title":"Systemic sclerosis patients present alterations in the expression of molecules involved in B-cell regulation","volume":"6","author":"Soto","year":"2015","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2022.121238_bb0175","doi-asserted-by":"crossref","first-page":"R18","DOI":"10.1186\/ar3242","article-title":"Dysregulated expression of MIG\/CXCL9, IP-10\/CXCL10 and CXCL16 and their receptors in systemic sclerosis","volume":"13","author":"Rabquer","year":"2011","journal-title":"Arthritis Res.Ther."},{"key":"10.1016\/j.lfs.2022.121238_bb0180","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jaut.2018.02.001","article-title":"TBK1: a key regulator and potential treatment target for interferon positive Sj\u00f6gren's syndrome, systemic lupus erythematosus and systemic sclerosis","volume":"91","author":"Bodewes","year":"2018","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.lfs.2022.121238_bb0185","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s13353-017-0415-4","article-title":"Expression of TLR7, TLR9, JAK2, and STAT3 genes in peripheral blood mononuclear cells from patients with systemic sclerosis","volume":"59","author":"Vre\u0107a","year":"2018","journal-title":"J. Appl. Genet."},{"issue":"2","key":"10.1016\/j.lfs.2022.121238_bb0190","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/art.41813","article-title":"Expansion of Fc\u03b3 receptor IIIa-positive macrophages, ficolin 1-positive monocyte-derived dendritic cells, and plasmacytoid dendritic cells associated with severe skin disease in systemic sclerosis","volume":"74","author":"Xue","year":"2022","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.lfs.2022.121238_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.770419","article-title":"Editorial: key players in systemic sclerosis: the immune system and beyond","volume":"12","author":"Guilpain","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2022.121238_bb0200","first-page":"iii23","article-title":"Immunological basis of systemic sclerosis","author":"Zuber","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.lfs.2022.121238_bb0205","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.2741\/1654","article-title":"Immunology of systemic sclerosis","volume":"10","author":"Artlett","year":"2005","journal-title":"Front. Biosci."},{"key":"10.1016\/j.lfs.2022.121238_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.758131","article-title":"Protein function prediction based on PPI networks: network reconstruction vs edge enrichment","volume":"12","author":"Zhou","year":"2021","journal-title":"Front. Genet."},{"issue":"24","key":"10.1016\/j.lfs.2022.121238_bb0215","first-page":"4784","article-title":"The PPI network and clusters analysis in glioblastoma","volume":"19","author":"He","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2022.121238_bb0220","doi-asserted-by":"crossref","first-page":"104065","DOI":"10.1016\/j.lpm.2021.104065","article-title":"Autologous stem cell transplantation in scleroderma","volume":"50","author":"Farge","year":"2021","journal-title":"Presse Med."},{"key":"10.1016\/j.lfs.2022.121238_bb0225","article-title":"Cyclophosphamide for connective tissue disease-associated interstitial lung disease","volume":"1","author":"Barnes","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"issue":"9","key":"10.1016\/j.lfs.2022.121238_bb0230","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1080\/14737159.2017.1356722","article-title":"An update on biomarker discovery and use in systemic sclerosis","volume":"17","author":"Matsushita","year":"2017","journal-title":"Expert. Rev. Mol. Diagn."},{"issue":"2","key":"10.1016\/j.lfs.2022.121238_bb0235","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.0906-6705.2005.00280.x","article-title":"Cellular and molecular mechanisms of bleomycin-induced murine scleroderma: current update and future perspective","volume":"14","author":"Yamamoto","year":"2005","journal-title":"Exp. Dermatol."},{"issue":"8","key":"10.1016\/j.lfs.2022.121238_bb0240","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00403-005-0635-z","article-title":"The bleomycin-induced scleroderma model: what have we learned for scleroderma pathogenesis?","volume":"297","author":"Yamamoto","year":"2006","journal-title":"Arch. Dermatol. Res."},{"issue":"4","key":"10.1016\/j.lfs.2022.121238_bb0245","first-page":"185","article-title":"Skin fibrosis: models and mechanisms","volume":"64","author":"Do","year":"2016","journal-title":"Curr. Res. Transl. Med."},{"key":"10.1016\/j.lfs.2022.121238_bb0250","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-1-4939-7113-8_3","article-title":"Intradermal injections of bleomycin to model skin fibrosis","volume":"1627","author":"Yamamoto","year":"2017","journal-title":"Methods Mol. Biol."},{"issue":"8","key":"10.1016\/j.lfs.2022.121238_bb0255","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00403-005-0635-z","article-title":"The bleomycin-induced scleroderma model: what have we learned for scleroderma pathogenesis?","volume":"297","author":"Yamamoto","year":"2006","journal-title":"Arch. Dermatol. Res."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522009389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522009389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T21:06:48Z","timestamp":1758402408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320522009389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":51,"alternative-id":["S0024320522009389"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2022.121238","relation":{},"ISSN":["0024-3205"],"issn-type":[{"type":"print","value":"0024-3205"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification and validation of key immune-related genes with promising diagnostic and predictive value in systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2022.121238","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"121238"}}